Reduced Chance of Hearing Loss Associated with Therapeutic Drug Monitoring of Aminoglycosides in the Treatment of Multidrug-Resistant Tuberculosis

about

Cross border, highly individualised treatment of a patient with challenging extensively drug-resistant tuberculosis.In vitro drug susceptibility of Mycobacterium tuberculosis for amikacin, kanamycin and capreomycin.

P2860

Q50118836-0C3C26A5-B556-4955-A88E-BB6B16202D7A Q50134142-7D7917A8-667C-4FF6-BBE0-07DCA7F6AB6B

P2860

Reduced Chance of Hearing Loss Associated with Therapeutic Drug Monitoring of Aminoglycosides in the Treatment of Multidrug-Resistant Tuberculosis

Item

http://www.wikidata.org/entity/Q39030684

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Reduced Chance of Hearing Loss ...... ltidrug-Resistant Tuberculosis

@en

Reduced Chance of Hearing Loss ...... tidrug-Resistant Tuberculosis.

@nl

type

Item

label

Reduced Chance of Hearing Loss ...... ltidrug-Resistant Tuberculosis

@en

Reduced Chance of Hearing Loss ...... tidrug-Resistant Tuberculosis.

@nl

prefLabel

Reduced Chance of Hearing Loss ...... ltidrug-Resistant Tuberculosis

@en

Reduced Chance of Hearing Loss ...... tidrug-Resistant Tuberculosis.

@nl

P1476

Reduced Chance of Hearing Loss ...... ltidrug-Resistant Tuberculosis

@en

P2093

D van Soolingen

http://www.w3.org/2001/XMLSchema#string

J A Dijkstra

http://www.w3.org/2001/XMLSchema#string

J F Borjas Howard

http://www.w3.org/2001/XMLSchema#string

J G W Kosterink

http://www.w3.org/2001/XMLSchema#string

J W C Alffenaar

http://www.w3.org/2001/XMLSchema#string

M E van der Meer

http://www.w3.org/2001/XMLSchema#string

R van Altena

http://www.w3.org/2001/XMLSchema#string

P2860

In vitro activities of fourteen antimicrobial agents against drug susceptible and resistant clinical isolates of Mycobacterium tuberculosis and comparative intracellular activities against the virulent H37Rv strain in human macrophages

Mechanism of resistance to amikacin and kanamycin in Mycobacterium tuberculosis.

Long term streptomycin toxicity in the treatment of Buruli Ulcer: follow-up of participants in the BURULICO drug trial.

American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America

Sensititre MycoTB plate compared to Bactec MGIT 960 for first- and second-line antituberculosis drug susceptibility testing in Tanzania: a call to operationalize MICs.

Audiologic monitoring of multi-drug resistant tuberculosis patients on aminoglycoside treatment with long term follow-up

Initial assessment of hearing loss using a mobile application for audiological evaluation.

Trimethoprim-sulfamethoxazole.

Multicenter laboratory validation of susceptibility testing of Mycobacterium tuberculosis against classical second-line and newer antimicrobial drugs by using the radiometric BACTEC 460 technique and the proportion method with solid media.

Does the dose matter?

P31

scholarly article

P356

10.1128/AAC.01400-16

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Tjip S van der Werf

P577

2017-02-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28069654

http://www.w3.org/2001/XMLSchema#string

P921

multiple drug resistance

P932

5328543

http://www.w3.org/2001/XMLSchema#string

Reduced Chance of Hearing Loss Associated with Therapeutic Drug Monitoring of Aminoglycosides in the Treatment of Multidrug-Resistant Tuberculosis

about

P2860

P2860

Reduced Chance of Hearing Loss Associated with Therapeutic Drug Monitoring of Aminoglycosides in the Treatment of Multidrug-Resistant Tuberculosis

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932